Fate Therapeutics Inc (FATE) EPS is poised to hit -0.43 next quarter: How Investors Can Make It Count the Most?
Witnessing the stock’s movement on the chart, on Thursday, Fate Therapeutics Inc (NASDAQ: FATE) had a quiet start as it plunged -6.76% to $2.07, before